Steroid-free. Clinically tested against a 1% hydrocortisone cream.
HYNERA

For healthcare professionals

A non-steroidal cream, compared with 1% hydrocortisone.

Summary of a randomised, split-side, non-inferiority study of a 0.20% Centella asiatica extract nanogel cream in adults with eczema.

30adults enrolled, 29 completed
6 weekstwice-daily application
1%hydrocortisone comparator
4outcomes met non-inferiority

Design

PopulationThirty adults aged 18 to 65 with bilateral eczematous lesions of comparable size (less than 10% difference)
Intervention0.20% w/w standardised Centella asiatica extract in a hyaluronic acid-grafted poly(N-isopropylacrylamide) nanogel cream, on one side
Comparator1% hydrocortisone cream on the contralateral side
AllocationRandomised, split-side; each participant served as their own control
DurationSix weeks; assessments at baseline and weeks 1, 2, 4 and 6
OutcomesErythema index, skin hydration, transepidermal water loss, skin pH, Investigator’s Global Assessment, pruritus visual analogue scale, patient satisfaction, safety
CompletersTwenty-nine (72.4% female; mean age 40.5 ± 10.8 years)

Results

−0.4690.095 −Δ0+Δ Favours Centella creamFavours 1% hydrocortisone ERYTHEMA INDEX · MEAN DIFFERENCE, 95% CI
Erythema indexBoth treatments significantly reduced erythema index at week 6. Non-inferiority to 1% hydrocortisone was demonstrated (95% CI of the difference, −0.469 to 0.095).
TEWL, hydration, pruritusEarly and sustained improvement from week 1 onward on both sides. Non-inferiority was demonstrated for all three.
Between-group differenceNo significant difference at any time point.
IGAImprovement increased over time on both sides, with earlier and higher proportions of more than 50% improvement on the Centella side.
Skin pHRemained within the physiological range.
TolerabilityOne mild, transient adverse event on the Centella side. Overall satisfaction was high on both sides.

The formulation

The active is a standardised Centella asiatica extract containing more than 80% triterpenoid glycosides, with madecassoside and asiaticoside at a fixed ratio of 1.5 ± 0.5.

The carrier is a self-assembled nanogel of hyaluronic acid grafted with poly(N-isopropylacrylamide). In the published characterisation it increased the aqueous loading of asiatic acid 250 to 400 fold, with encapsulation efficiency above 86% and a transition at 34 to 35 °C.

The cream contains no corticosteroid and no added fragrance. The full ingredient list is on the Ingredients page.

Sources

  1. Efficacy of 0.20% Centella asiatica extract incorporated with hyaluronic acid-based nanosphere formulation compared with 1% hydrocortisone cream for eczema. European Academy of Dermatology and Venereology Congress 2026, e-Poster P0145.
  2. Self-assembled hyaluronic acid nanogel for asiatic acid. Polymers, 2021. doi.org/10.3390/polym13234071
  3. The extract as capsules in healthy volunteers, phase 1. Planta Medica, 2019. doi.org/10.1055/a-0835-6671
  4. A 0.05% gel of the extract after laser resurfacing, split-face, placebo-controlled. Journal of Alternative and Complementary Medicine, 2020. doi.org/10.1089/acm.2019.0325

Talk to us

If you would like the poster or a conversation with our scientific team, write to us and say you are a healthcare professional.

Contact the team